Navigation Links
Medco Tops Industry on Fortune's List of 'World's Most Admired Companies' for Fourth Consecutive Year
Date:3/7/2011

FRANKLIN LAKES, N.J., March 7, 2011/PRNewswire/ -- Medco Health Solutions, Inc. (NYSE: MHS), captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on Fortune's "World's Most Admired Companies" list for the fourth consecutive year.  Medco earned the highest ranking across all nine attributes within that sector: innovation, people management, use of corporate assets, social responsibility, quality of management, financial soundness, long-term investment, quality of products/services, and global competitiveness.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

Medco is also among the most admired companies in New Jersey, and is one of only two companies in the state to earn a #1 ranking for its industry.

The Fortune World's Most Admired Companies list is a report card on corporate reputation. In partnership with the Hay Group, Fortune surveyed more than 673 companies across 57 industries and 32 countries. To establish the rankings, executives, directors, and securities analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results will be featured in the March 7 issue of Fortune magazine.

"We are once again honored to be ranked the highest of our industry peers, and I am thankful to our more than 20,000 employees who work hard to keep Medco a Most Admired company," said Medco Chairman and CEO David B. Snow Jr. "To continue to earn this No. 1 position in our industry demonstrates that Medco's business model and commitment to making medicine smarter is delivering value for our members, clients and shareholders."

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees worldwide dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2010 revenue of nearly $66 billion, Medco ranks 35th on the 2010 Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. 

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medco to Present at the Citi 2011 Global Health Care Conference
2. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
3. Medco Announces Date for Release of Fourth-Quarter and Full-Year 2010 Financial Results
4. Medco CEO to Present at Upcoming Healthcare Conferences
5. Medco Extends URAC Accreditation to Drug Therapy Management, PBM
6. Medcos 2011 National Medicare Prescription Drug Plan (PDP) Earns CMS 5-Star Quality and Performance Rating
7. Medco to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
8. Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks
9. Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevadas Future
10. Medco Announces Date for Third-Quarter 2010 Financial Results
11. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016  Labvantage Lx, a newcomer to the ... sexual enhancement product, EnduramenT. Setting a new standard ... a patented biomedical breakthrough molecule that promotes the ... responsible for many biological functions including erectile function. ... Forgoing the use of prescription medications, scientists working ...
(Date:2/8/2016)... 2016  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter and year-end 2015 results after the Nasdaq market ... host a live conference call and webcast to discuss ... afternoon, February 11, 2016 at 4:30 p.m. Eastern Time ... --> http://www.neurocrine.com . --> Participants can ...
(Date:2/8/2016)... 2016 --> ... "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, ... Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020", published ... the forecast period of 2015 to 2020. The market ... CAGR of 10.5% from 2015 to 2020. ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 2016 , ... The Association of Home Care Coding & ... Health and Hospice ICD-10 Transition Workgroup are working closely with the American Hospital ... to address concerns over the use of 'A' as the seventh character indicating ...
(Date:2/8/2016)... ... 08, 2016 , ... Guruji Mahendra Kumar Trivedi is offering 3 days of ... of his birthday on February 10th. During this time, people can achieve better ... over 250,000 people from over 40 different countries as an ÔÇťordinary man with an ...
(Date:2/7/2016)... Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... correct pelvic organ prolapse with the latest techniques and the most minimally invasive ... for pelvic organ prolapse, particularly after menopause. Other risk factors include surgery to ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... ... , ... With the FCPX LUT: Summer pack from Pixel Film ... LUT is a Lookup Table that contains a mathematical formula for modifying an image. ... By manipulating each pixel, LUT's can change each color range differently, it gives the ...
Breaking Medicine News(10 mins):